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Abstract

INVESTIGATION OF VIEWS ON MENTAL HEALTH TREATMENT
SEEKING
Huy Tran
Thesis Chair: Sarah M. Sass, Ph.D.
The University of Texas at Tyler
May 2015
Although research exists regarding barriers to mental health care for individuals
with depression and anxiety disorders, few studies have compared characteristics of those
who seek treatment versus those who do not seek treatment for psychological distress
associated with these disorders. Such studies are needed in order to better understand
factors involved in treatment seeking and treatment abstention. The present study
addresses treatment seeking and treatment abstention in individuals with major
depressive disorder (MDD) and generalized anxiety disorder (GAD), in order to
understand barriers to treatment in this population. Results indicate that the groups did
not significantly differ on their gender, finances, sexual orientation, ethnicity, and grade
classification. Results also suggest that those who seek treatment associate less stigma
with mental health than those who do not seek treatment. Finally, both groups prefer to
handle their own problems and think that their problems would eventually resolve
themselves. These results may be helpful in informing outreach and prevention efforts
targeted to an MDD and GAD population.
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Introduction
There exists a very large treatment gap in the area of mental health disorders
within the United States. A treatment gap is defined as the number of people who need
treatment but are not receiving it, even though effective treatment is available.
Approximately 28% of Americans will suffer from an anxiety or depressive disorder
(Kessler et al., 2005). The treatment gap is approximately 68% for GAD and 72% for
MDD (Kohn et al, 2004). Indeed, a large percentage of people who need treatment are
not receiving it with direct and indirect ramifications (Wang et al., 2005).
Due to depressive disorders alone, lost productivity in the workforce accounts for
a $23 billion cost to the United States annually (Kohn et al., 2004). Wang, Simon, and
Kessler (2003) reported that about 44% of those surveyed in the National Comorbidity
Study (NCS) were absent for at least one day of work in the last three months due to
complications regarding major depression. Additionally, compared to disorder-free
individuals, they were 27 times more likely to experience work loss (Wang et al., 2003).
For GAD, Wittchen (2002) states that it may lead to complete disability, diminished
productivity at work, and is as much of a burden on society as depression. Moreover,
individuals with comorbid GAD and MDD experience a higher level of disability
(Wittchen, 2002). In addition to GAD and MDD being problematic disorders when not
comorbid, their comorbidity exacerbates economic costs to society.
Untreated depressive and anxiety disorders also affect several aspects of an
individual’s life, including personal and social domains. Depressive disorders may affect
1

an individual’s workplace functioning, interpersonal relationships, marriage, educational
achievement, and employment (Collins, Westra, Dozois, & Burns, 2004). Children
affected by anxiety disorders may have poor academic performance, a greater likelihood
of being suspended, and run away from home (Collins et al., 2004). Adults with anxiety
disorders face problems in interpersonal relationships, including family interactions
(Collins et al., 2004). Despite efficacious treatment such as cognitive behavioral therapy
and pharmacological options for anxiety and depressive disorders (Dobson, 1989), the
treatment gap remains problematic.
Literature Review
A Closer Look at Treatment Barriers
There is currently a scarcity of data in the research literature pertaining
specifically to individuals with MDD, GAD, and comorbid MDD/GAD and their
respective barriers to treatment. Table 1 lists the most common barriers to treatment
seeking for anxiety and depression (Collins et al., 2004). In order to narrow down the
scope of this research project, only barriers on an individual level are examined.
However, provider and systemic factors contribute to the overall treatment gap problem
and will be considered further in the Discussion section.
In addition to the barriers to treatment noted by Collins et al. (2004), Vogel,
Wester, and Larson (2007) identified several general reasons why individuals with
anxiety and depression may avoid counseling, referred to as “avoidance factors.” These
barriers include social stigma, treatment fears, fear of emotion, anticipated utility and
2

risks, and self-disclosure. More specifically, treatment fears are described as the fear of
how one may be treated and viewed by a mental health professional which may delay or
disrupt treatment-seeking behaviors. Fear of emotion is described as the fear of
discussing and experiencing painful emotions which may delay or disrupt treatmentseeking behaviors. Finally, anticipated utility and risks is described as the individual’s
perception of how useful treatment will be, and whether the risks outweigh the benefits.
It is important to note that Vogel et al. (2007) describe barriers to counseling whereas
Collins et al. (2004) describe barriers to medication in addition to counseling for mental
health problems.
The present study examines barriers to both medication and counseling using a
student sample. In a related study, Downs and Eisenberg (2012) examined treatmentseeking behaviors and perceptions in a college sample endorsing suicidal ideation. The
researchers did not explicitly state whether their participants met criteria for MDD and/or
GAD. Still, suicidality is a common symptom among those with MDD and/or GAD, and
there is a possibility that those who express suicidality may meet criteria for MDD and/
or GAD. In fact, Downs and Eisenberg (2012) state that “9 out of 10 people who die by
suicide in the United States have probable mental illnesses, and depressive symptoms
have been associated with 95% of college students with reported suicidal ideation. ”
Another important statistic that was reported is that less than half of students screening
positive for depression or anxiety disorders received any mental health services in the last
12 months. It is evident that the researchers believe that there is a treatment gap among
3

the average college population suffering from depression and anxiety disorders, and that
this gap can lead to suicidal ideation.
In the Downs and Eisenberg (2012) study, participants were asked to rate their top
barriers to treatment. The majority of participants stated that they did not seek treatment
because they preferred to deal with their own problems, perceived their stress as being
“normal,” and questioned whether their problems warranted treatment. Preferring to
solve one’s own problems is a common trend in the treatment-seeking literature. This
self-reliance is also reflected in a study completed by Meltzer et al. (2003). However, in
addition to participants reporting that they prefer to handle their own problems, in this
study they also questioned the efficacy of treatment, worried about social stigma, and
thought that their problems would eventually improve without treatment. Overall, it
appears that a lack of insight into the chronicity and severity of mental health issues can
be a major barrier for treatment seeking (Meltzer et al., 2003). Furthermore, high
personal stigma was correlated with a lower perceived need for help in an untreated
population (Schomerus et al., 2012).
What other factors should be considered? In a study that involved approximately
347 adults living in Great Britain, Meltzer et al. (2003) found that socio-demographic and
socioeconomic factors were not largely correlated with a reluctance to seek treatment.
Instead, the researchers discovered that symptom severity played a more important role in
seeking treatment. Counterintuitively, the more severe the symptoms, the more likely it
was for participants to express reluctance. One important caveat of this study is that the
4

researchers only interviewed participants who “had not been to see a doctor when they or
their family and friends thought they should” within the past year. Participants who did
not seek treatment because they did not perceive a need were not interviewed. This is an
important distinction because a lack of knowledge about disorders has been found to be a
barrier to treatment seeking. Another caveat is that the researchers collapsed ethnicity
into four distinct categories: White, Black (African, African-Caribbean, and ‘Black
Other’), South Asian (Indian, Pakistani, and Bangladeshi), and ‘Other.’ There could be
differences within these groups that should be examined. Of those participants who did
endorse a reluctance to seek treatment, two of the most common reasons given were
“…not thinking anyone could help,” and “…a problem one should be able to cope with.”
This study, despite the caveats mentioned, present another facet to the treatment gap
problem. That is, the severity of an individual’s mental health problems may contribute
to their unwillingness to seek help despite needing it.
Phillips, Mayer, and Aday (2000) reported disparities in treatment barriers for
different racial/ethnic groups in the United States in a separate study. The study states
that minorities, especially Hispanics, reported barriers more frequently than non-Hispanic
whites. Hispanics were most likely to endorse problems in obtaining care compared to
other racial/ethnic groups. Asian Americans were most likely to report dissatisfaction
with the quality of care received. The authors suggest that continuity of care may be a
problem in this group. African Americans more frequently reported barriers than nonHispanic whites, but less so than other racial/ethnic groups. Individuals with insurance,
5

across all racial/ethnic groups, reported fewer barriers to care but “insurance alone did
not guarantee better access to care” (Phillips et al., 2000). In fact, about two-thirds of
families who reported having barriers to care were insured. This study highlights the
importance of examining cultural barriers that racial/ethnic populations may face when
attempting to access care. Although having insurance and the ability to pay is important,
being insured is not a guarantee for a high quality of treatment. Researchers and
advocators must also look at stigma, language, cultural, and socioeconomic barriers—
combined—in order to fully comprehend the needs of these populations.
In addition to investigating barriers to treatment, examining characteristics of
individuals who display positive treatment-seeking behaviors (i.e., those who seek
treatment) should be examined as well in order to develop a better understanding of what
motivates treatment seeking. In the current literature, there is a paucity of data examining
attitudes and beliefs of treatment seekers for MDD and/or GAD. However, Thomas,
Caputi, and Wilson (2014) found several attitudinal factors that may predict positive
treatment-seeking behavior in an undergraduate sample of psychology students who
experienced distress. Their results indicate two attitudes that were endorsed by
participants who intended to seek treatment for psychological distress: “If I believe that I
was having a mental breakdown, my first thought would be to get professional attention,”
and, “A person with an emotional problem is not likely to solve it alone; he or she is
likely to solve it with professional help.” As previously noted, two common barriers to
treatment seeking include a lower perceived need for help and the desire to solve one’s
6

own problems. The results from this study indicate that those who intended to seek
treatment were more likely to do so if they perceived a need for help and believed that
one is unlikely to resolve one’s own mental health problems.
Research Questions and Hypotheses
The present study’s focus was to examine common barriers to treatment amongst
a student sample meeting criteria for MDD and/or GAD by exploring differences
between treatment seekers and non-treatment seekers. The goal of the study was to
identify demographic, attitudinal, and other barriers in accessing care that could be
targeted for change and could inform future outreach efforts.
Demographic Differences. Are there demographic differences between the
treatment and non-treatment seeking groups? For example, are treatment seekers more
likely to be female? How does age, grade classification, sexual orientation, ethnicity, and
symptom severity factor in? Results might indicate that participants belonging to certain
demographic groups are more or less likely to seek treatment than others. This
information would help inform advocacy groups and also help as a starting point for
outreach efforts.
Attitudinal Differences. Another purpose of this study was to find differences in
attitudes between treatment and non-treatment seekers. Attitudes are defined as a way of
thinking about mental health and people who have mental health problems for the
purpose of this study. Negative attitudes about mental health, for example, includes
thinking that seeking treatment makes an individual less likable or that a person who
7

seeks treatment is weak. A positive attitude includes thinking that seeking treatment is a
sign of personal strength, or that one would be friends with someone with a mental health
problem.
Other Barrier Differences. In addition to demographic and attitudinal barriers,
other barriers will also be examined. One example of a barrier that could inhibit treatment
seeking is holding a belief that one can handle one’s own problems. In fact, a previous
study found that non-treatment seekers prefer to handle problems on their own and are
less likely to seek treatment (Downs & Eisenberg, 2012; Meltzer et al., 2003).
Results from this study may be helpful in changing perceptions of treatment and
mental health in individuals experiencing mental health symptoms as well as in their
friends and families. For instance, if results indicate that those with MDD and/or GAD
are less likely to seek treatment if they perceive treatment in a negative light or that they
can handle their own issues, then mental health advocates can target those specific
perceptions through various outreach campaigns (e.g., TV public service announcements,
university and community awareness and outreach days, local and national support
groups). In conclusion, results from this study may contribute to increasing mental health
literacy and educating the public about the effectiveness of treatment while lessening the
associated stigma of treatment for mental health issues.
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Method
Participants
A total of 549 undergraduate participants were screened via a Qualtrics online
questionnaire (87 in Fall 2013, 133 in Spring 2014, 202 in Fall 2014, 127 in Spring
2015). Thirty-five participants met criteria based on meeting cut-off scores on two or
more prescreening questionnaires (discussed further below) and were invited to complete
a clinical interview using the Mini-International Neuropsychiatric Interview Plus 6.0
(Sheehan et al., 1998) in order to verify diagnostic status. These 35 participants were
also asked to complete several questionnaire measures of treatment-seeking attitudes and
behaviors. Participants ranged in age from 18 to 64. This study is IRB-approved and all
participants must consent to participate before engaging in the study.
Procedure
Phase One. In the first phase, students were asked to complete multiple
screening questionnaires assessing their current and past symptomatology. Based on
these scores, students who met criteria were asked to participate in the second phase of
the study which included a structured diagnostic interview. Specifically, two
questionnaires were used to screen for worry symptoms in the initial phase of the study:
the Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & Borkovec, 1990;
Molina & Borkovec, 1994; Behar et al., 2003; Fresco et al., 2003) and the Generalized
Anxiety Disorder seven-question assessment (GAD-7; Spitzer, Kroenke, Williams, &
Lowe, 2006). Two questionnaires were also used to screen for depression: an 8-item
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subset of the Anhedonic Depression subscale of the Mood and Anxiety Symptom
Questionnaire (MASQ; Watson, Clark, et al., 1995; Watson, Weber, et al., 1995;
Nitschke, Heller, Imig, McDonald, & Miller, 2001) as well as the revised Center for
Epidemiologic Studies-Depression Scale (CESD; Radloff, 1977; CESD-R; Eaton et al.,
2004). The prescreening questionnaires took approximately 30 minutes to complete.
Anxiety Measures.
Penn State Worry Questionnaire. The PSWQ is a 16-item questionnaire designed
to measure chronic worry. In a college sample, the PSWQ had high internal consistency
(coefficient alphas = .92), and stability over time. Correlations for test-retest stability of
the PSWQ ranged from r = .75 to r = .92 over several time intervals (2 weeks, 4 weeks,
and 8-10 weeks – Behar et al., 2003). Most importantly, the questionnaire distinguishes
anxious samples from non-anxious samples. Overall, the PSWQ is an effective measure
for assessing “clinically significant, pathological worry” in a college population (Molina
& Borkovec, 1994). The present study uses a cut-off score of 62, as suggested by Behar,
Alcaine, Zuellig, and Borkovec (2003).
Generalized Anxiety Disorder-7-Questionnaire. Another measure that the present
study uses for measuring anxiety is the GAD-7. The GAD-7, is a 7-item questionnaire
measuring anxiety symptoms typical of GAD. In a study assessing symptoms in a
population undergoing addictions treatment, Delgadillo et al. (2012) found that the GAD7 demonstrated high internal consistency (Cronbach’s alpha = 0.91). Additionally, a
GAD-7 score of 9 or greater had a sensitivity of 80% and specificity of 86% for any
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anxiety disorder. In other words, the questionnaire was sensitive enough to detect most
participants who had an anxiety disorder, while being specific enough to target only those
with GAD. In a separate study, of more than 2,500 people assessed, the GAD-7 was
found to have high sensitivity and specificity with a cut-off score of 10 or greater, and
was found to have good reliability and validity (Spitzer et al., 2006). Overall, the GAD-7
is an effective and valid tool for screening anxious symptoms that are characteristic of
GAD (Spitzer et al., 2006; Delgadillo et al., 2012). The present study uses a cut-off score
of 10, as suggested by Spitzer et al., 2006.
Depression Measures.
Mood and Anxiety Symptom Questionnaire Anhedonia Subscale. The MASQ-AD
8 is an 8-item subset of the Anhedonic Depression subscale of the Mood and Anxiety
Symptom Questionnaire. The scale is cited as having good convergent and discriminant
validity in undergraduate samples (Bredemeier et al., 2010). Additionally, the scale
reliably predicted whether participants met criteria for a current Major Depressive
Episode. In the present study, the MASQ-AD 8 was used to screen for current and past
MDE. The instructions were slightly altered so that participants would frame their
answers either during the past week (for current) or prior to that period (for past). A cutoff score of 23 achieves a balance of sensitivity and specificity (Bredemeier et al., 2010)
and was used as the cut-off score in the present study.
Center for Epidemiologic Studies-Depression Scale Revised. The CESD-R was
also used to measure depression symptoms. The CESD-R is a revision of the original
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CESD scale and has been shown to be as reliable and valid as the original scale. One
advantage is that this revised scale is “more relevant to the current definitions of major
depression” (Eaton et al., 2004). The researchers also attest to the CESD-R’s excellent
internal reliability and face and construct validity. Furthermore the test-retest reliability
and criterion validity of the CESD-R are “expected to be very good” (Eaton et al., 2004).
The lowest score for having a possibility of meeting depression criteria is 16. The
present study uses a cut-off score of 16 or above.
These questionnaires were selected based on their strong psychometric properties
as evidenced by the current research literature. Finally, the justification for using more
than one measure per domain is to have greater confidence that participants will meet
criteria based on a structured diagnostic interview. The structure diagnostic interview was
used as another layer to understanding the participants’ symptoms.
Phase Two. After the initial screening step, qualifying participants were invited
to participate in the second phase of the study (i.e., the post-screening) by email or phone.
Once the subject agreed to participate, they were asked if they would consent to being
audio recorded for training and supervisory purposes. If they declined, the interview
would continue without the audio recording. No participants declined being recorded.
After completing the interview, participants completed a computerized self-assessment
including demographic and opinion-based questions relating to mental health and
treatment seeking. All participants were given an informational sheet advising them of
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available mental health resources located in the local community at the conclusion of
each phase two session.
Structured Diagnostic Interview (MINI Plus 6).
MINI Plus 6. Once a participant met criteria for either anxiety or depression
domains, they were invited to an in-person one-on-one interview conducted by one of
three trained graduate student researchers. Once the subject agreed to participate, they
were asked to consent to being audio recorded for training and supervisory purposes.
Each participant was administered the Mini-International Neuropsychiatric Interview
Plus 6.0 brief structured diagnostic interview.
Developers of the MINI conducted validity and reliability studies comparing it to
the Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version,
Patient Edition and the Composite International Diagnostic Interview (SCID-I/P; First,
M., Spitzer, R., Gibbon, M., & Williams, J., 2002; CIDI; Robins, et al., 1988). Results
from Sheehan et al. (1998) indicate that the MINI has validity and reliability properties
that are similar to the SCID-I/P and CIDI. However, one advantage is that it can be
administered in a shorter duration. This tool was chosen for its good psychometric
properties and relatively short administration time.
All participants were asked to disclose information about their mental health care
history, their family’s mental health care history, and their attitudes and behaviors
regarding treatment seeking in the post-screening survey. An example of a question
assessing a treatment-seeking attitude: “How satisfied are you with the effectiveness of
13

the psychotherapy or counseling that you received, if any?” For the actual survey used,
please refer to the post-screening questionnaire in Appendix B.
In addition to custom-designed questions that assess barriers in accessing mental
health care, the Barriers to Access to Care Evaluation scale (BACE; Clement et al., 2012)
was included as part of the post-screening questionnaire. Participants were asked to rate
how much a given factor might prevent them from seeking treatment. For example:
“Concern that I might be seen as weak for having a mental health problem” would be
rated by a participant from “not at all” to “a lot.” Please refer to the Appendix B for a
copy of the full BACE questionnaire used in phase two.
At the end of the post-screening, participants were thanked for their participation
in the study. Each participant was given an informational sheet with a list of available
resources in the community. Each participant was also compensated with a gift card in
the amount of 15 dollars to 10 dollars, based on funds availability. The post-screening
session was expected to last one to two hours per participant.
Data were analyzed using descriptive and inferential statistics on participants’
responses to the questionnaires and measurements. Relationships between treatment
seekers and non-treatment seekers were examined. Separate t-tests comparing treatment
seekers and non-treatment seekers on symptoms, ratings of level of functioning, and
questionnaire measures of perceptions of stigma and treatment efficacy were conducted.
The two groups were compared via chi square tests on demographic factors in order to
assess whether groups differed on demographic factors.
14

Results
Phase One Sample
Of the 549 participants screened for the study, 70% (n = 385) identified as
White/Caucasian and 72% (n = 396) were female, both consistent with the race/gender of
the undergraduate population majoring in psychology in the Psychology and Counseling
department. Freshman students comprised 40.6% (n = 223) of the sample. Please refer to
Tables 2 through 6 for more demographic details.
Phase Two Sample
Thirty-five participants were invited to the second phase of the study and
successfully completed it. As mentioned above, these participants were administered the
MINI Plus 6 diagnostic interview and then the treatment-seeking attitudes and behaviors
questionnaire. Of those administered the diagnostic interview, 12 participants met
criteria for a history of Major Depressive Disorder, 12 for Generalized Anxiety Disorder,
and 22 for another disorder (e.g., bipolar disorder, panic disorder with agoraphobia,
PTSD, etc.). Seven participants met no criteria for a disorder. Please refer to Table 11 for
more information.
Regarding trends in the treatment-seeking questionnaire, of the 35 participants, 25
endorsed seeking medication, psychotherapy, or both (i.e., treatment seekers), and 10
denied seeking any type of treatment (i.e., non-treatment seekers). The treatment seekers
sought services for problems with anxiety, depression, adjustment problems, and
physiological problems such as insomnia.
15

Results of Demographic Differences. Regarding whether self-reported financial
factors affected treatment seeking, there was no significant difference between the
groups; 2(5, N = 35) = 6.83, p = .23. This result suggests that financial barriers did not
seem to influence non-treatment seekers’ decision to not seek treatment. This result
supports research in the literature concluding that a person’s finances is not the sole
determinant of whether or not they seek treatment and that other factors should be
examined (Phillips, Mayer, & Aday, 2000). There were no gender differences between
the two groups, 2(1, N = 35) = .08, p = .77. Regarding ethnicity and grade classification,
there was no significant difference between the groups; 2(4, N = 35) = 1.97, p = .74 and

2(4, N = 35) = .89, p = .93, respectively.
When examining whether there was a difference in treatment-seeking rates in
those who had past and/or present MDD and those who did not, results suggest a
difference. Those with MDD past and/or present (N = 12) were more likely to seek
treatment than those without MDD past and/or present (N = 23); 2(1, N = 35) = 7.30, p =
.007. These results were not found in the sample who had GAD. For the GAD sample,
there was no significant difference between those who were diagnosed with GAD and
those who were not in terms of their treatment-seeking rates; 2(1, N = 35) = .11, p =
.735. A Chi-square test was conducted to test whether sexual orientation affected
treatment seeking. Results indicate that, in this sample, participants’ sexual orientation
did not significantly affect treatment-seeking rates; 2(4, N = 35) = 6.94, p = .139. Please
16

refer to Tables 12 – 16 for more information. Finally, to test whether symptom severity
had an impact on treatment seeking behaviors, the present study assigned each phase two
participant a Global Assessment of Functioning score (GAF). Results from an
independent samples t-test analysis indicated no significant difference between the
groups and their GAF scores; t (33) = 1.18, p = .246.
Results of Attitudinal Differences. Treatment seekers differed from nontreatment seekers on their self-report of the influence of stigma as measured by our six
items stigma questionnaire (a list of these questions can be found in Appendix B,
question 9.1). An independent samples t-test was conducted to compare how each group
responded to stigma items. The results indicate that there was a significant difference in
how much treatment seekers (M = 2.23, SD = .44) and non-treatment seekers (M = 2.62,
SD = .37) attached stigma to mental health treatment; t (33) = 2.49, p = .02. This result
indicates that non-treatment seekers attach slightly but reliably more stigma to mental
health treatment than do treatment seekers in this sample. A subscale of the BACE was
also used to tap into the stigma construct. An independent samples t-test was conducted
on the means of participants’ scores on a stigma subscale of the BACE. These questions
gauged how much stigma acted as a barrier to treatment seeking. Results indicated that
there was no significant difference in the way that treatment seekers (M = .87, SD = .64)
and non-treatment seekers (M = .74, SD = .51) answered these questions; t(33) = .56, p =
.58. This result suggests that this sample did not vary in their responses regarding
whether stigma affects their treatment seeking rates.
17

In addition to stigma, participants were also assessed on their attitudes regarding
the efficacy of medications, psychotherapy, and both medications and psychotherapy
together, for people their age. An independent samples t-test conducted on the groups
indicate that there that is no significant difference in how effective treatment seekers and
non-treatment seekers perceived medication t(33) = 1.05, p = .302, psychotherapy t(33) =
.53, p = .597, and both combined t(33) = .51, p = .615. Thus, when asked about the
efficacy of each type of treatment for people their age, treatment seekers and nontreatment seekers did not significantly differ in their answers.
Results of Barrier Differences. There was no significant difference on the mean
of all BACE questions for treatment seekers (M = 89, SD = .46) versus non-treatment
seekers (M = .92, SD = .37); t(33) = -.14, p = .89. When looking at these results, one
might conclude that, although non-treatment seekers attach more stigma to mental health
than treatment seekers as measured by the six item stigma questionnaire, it is not a
significant treatment barrier for them. However, the six item stigma questionnaire
assessed the amount of stigma participants attached to mental health in general while the
BACE stigma subscale measured whether stigma was a barrier to treatment seeking.
On the BACE scale, participants rated each barrier on a scale from 0 to 3 (with 0
being not at all concerned and 3 indicating “a lot” of concern). The top three barriers for
treatment seekers were: Wanting to solve the problem on my own (N = 25, M = 1.76, SD
= 1.09), thinking the problem would get better by itself (N = 25, M = 1.56, SD = .92), and
concern about what my family might think, say, do or feel (N = 25, M = 1.36, SD = 1.22).
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Of the non-treatment seeking participants, the top three barriers were: Wanting to solve
the problem on my own (N = 10, M = 2.60, SD = .70), dislike of talking about my
feelings, emotions or thoughts (N = 10, M = 1.60, SD = .97), and thinking the problem
would get better by itself (N = 10, M = 1.40, SD = 1.17). Please note that both treatment
seekers and non-treatment seekers reported “wanting to solve the problem on my own”
and “thinking the problem would get better by itself” as two of their top three barriers,
out of a list of 30 possible barriers.
Discussion
By understanding how individuals view treatment seeking, the mental health
community may be better equipped to inform policy, increase mental health literacy, and
diminish the treatment gap. Individuals who seek and receive adequate treatment
experience an improvement in their quality of life. Remission rates in depression and
GAD are low, and these disorders tend to be chronic in nature. In addition, future public
tragedies could be prevented if more people affected by mental health problems sought
treatment. One major aim of this research study was to provide an additional layer of
understanding on the topic of treatment-seeking attitudes and behaviors.
The data collected thus far suggests many similarities and differences between
treatment and non-treatment seekers. For example, both treatment and non-treatment
seekers had similar ratings for the perceived helpfulness of medications, psychotherapy,
and medication/psychotherapy combined. Both groups also agreed that psychotherapy is,
in general, more helpful than medications for individuals of their age. Another similarity
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exists in the participants’ attitude towards stigma. There was a trend for both groups to
have very low levels of personal stigma towards those who receive mental health
treatment. However, many participants think that others do not think very highly of
people with a mental health problem based on how participants rated the items on the 9.1
stigma questions. This discrepancy between personal and public stigma can help explain
the treatment gap. Misperceptions about how the general public views those with a
mental health problem can stifle treatment seeking behaviors. It is very interesting that
individual perceptions about mental health may be shifting towards less stigmatization,
yet individuals are worried the general public may not think highly of those who receive
mental health treatment.
Another finding is that non-treatment seekers differed significantly from
treatment seekers in the way that they responded to a set of questions measuring how
much stigma they attached to mental health (i.e., the six item stigma questionnaire).
Treatment seekers, on average, attached less stigma to mental health than did nontreatment seekers based on results from the six item stigma questionnaire. However, the
groups did not differ significantly in their responses regarding stigma on a subset of
questions in another measure (BACE). One possible explanation for this discrepancy is
that the six item stigma questionnaire measured directly how much stigma participants
attached to mental health. The other set of questions, the BACE stigma subscale, gauged
how much stigma acted as a barrier for participants. This difference in how the questions
are worded could explain why there is a discrepancy. Furthermore, participants might
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attach stigma to mental health but this attachment alone does not act as a barrier to
treatment seeking.
While mental health stigma alone does not explain the reason for the treatment
gap in the present study, perhaps additional factors might provide more clarity. Gender,
sexual orientation, ethnicity, grade classification, availability of funds, and symptom
severity were examined to determine their impact on treatment seeking. Results from this
study indicate that participants did not differ in each of these categories. It is interesting
that there was no significant difference in gender composition in the treatment seeking vs.
non-seeking groups. However, more female than male participants in both groups reflects
the college sample that was surveyed (with more female than male psychology majors).
In addition to these demographic factors, we also examined if there was a
significant difference in the amount of participants with MDD or GAD who sought
treatment. Every participant with a diagnosis of MDD past and/or present in our sample
reported being a treatment seeker. With GAD, there was no significant difference in the
amount of treatment versus non-treatment seekers. This result suggests that those
diagnosed with or meeting criteria for MDD are more likely to seek treatment than those
meeting criteria for GAD. Perhaps it is the case that depression is more well-known than
GAD; advertisements for depression medication far outnumber the ones for anxiety.
Additionally, the symptoms of GAD might be erroneously attributed to personality traits
rather than to a treatable disorder. Another interpretation, given the population of our
college sample, is that high anxiety and worry are considered norms, and thus
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participants preferred to resolve their anxiety problems on their own without seeking
treatment.
This study is only a small piece of the puzzle and other important pieces include
systemic- and provider-level barriers. For instance, if participants are not aware of
available resources in their community, then it is logical that they will not successfully
receive treatment for their mental health issues. Likewise, if a primary care physician
does not refer them to appropriate resources, then the individual might not receive the
services they need. A future direction of this study might aim to encapsulate additional
levels of barriers, such as the systemic and provider levels.
One major limitation of the sample is lack of power associated with a relatively
small sample size. While treatment seekers comprised 25 of the 35 participants in phase
2, non-treatment seekers comprised 10. Several efforts have been made to increase the
amount of non-treatment seekers in the sample, but overall this group has been
challenging to recruit. Another limitation of this study is that recruitment is confined to a
university sample. However, the sample does have clinically significant anxiety and/or
depression and the majority met DSM criteria for GAD and/or MDD, ensuring
generalizability to the wider population of GAD and MDD. Another limitation lies in the
nature of self-reported data. Data self-reported by participants on the questionnaires and
in the interview was not independently verified for accuracy (e.g., against the
participant’s medical or mental health records) in the present study due to feasibility and
privacy issues.
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Findings from this study suggest that screening for mental health symptoms in the
college population is important. Those with GAD, for example, might not know that they
have a treatable condition. Screenings will provide insight into their symptoms. Then,
those scoring highly on the screenings should be encouraged to seek treatment with the
appropriate referrals. In addition to screenings, mental health professionals and other
advocates can educate the public about mental health stigma to dispel the commonly held
belief that seeking treatment means that one is weak or unable to handle one’s own
problems. After all, participants, as a whole, endorsed as a top barrier in the present study
that they preferred to handle their own problems. For non-treatment seekers, they also
endorsed that they did not like to discuss their emotions and feelings, and that they
thought their problems would eventually get better with time. Screeners and outreach
members can educate participants about the chronic course of untreated mental health
disorders and about the beneficial effects of mental health treatment.
Despite the current limitations, results should contribute to the literature
regarding how individuals meeting criteria on prescreening measures for MDD and GAD
conceptualize treatment-seeking behaviors. This information can be used to inform
mental health practitioners as well as individuals suffering from GAD and MDD
regarding barriers and motivators for treatment. Ultimately, this work could also be
incorporated into future research, outreach, and intervention efforts. An increase of
treatment seekers could mean an increase in those who receive adequate treatment,
leading to more people who are healthy and productive members of society.
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Table 1. Barriers to Treatment for Anxiety and Depression
Level

Barrier

Individual

Willingness to disclose problems
Fear of stigma and embarrassment
Lack of time for treatment
Negative stereotypes of treatment
Presence of comorbid medical problems
Cultural factors
Demographic factors (age, marital status)
Geographic influences
Desire to handle problems on one’s own
Lack of awareness of available treatment
Minimizing severity of problems
Degree of distress and disruption of symptoms
Readiness for change

Provider

Underdetection within primary care sector
Lack of knowledge of mental health problems
Preoccupation with possible organic pathology
Skill in assessing mental health difficulties
Busyness and structure of practice
Willingness to diagnose and treat mental health issues
Stigma regarding discussing mental health issues
Somatizing patient presentation style

Systemic
Level of distress in presentation
Limited physician access to mental health services
Lack of awareness of range of effective treatment options
Primary care guidelines emphasizing pharmacotherapy
Limited availability of specialty mental health providers
Lack of integration of mental health services in primary
care
Low rates of provision of evidence-based care in mental
health services
Limited training in evidence-based care among mental
health training programs
Limited response rates to empirically supported
treatments

Collins et al., 2004
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Table 2. Racial and Ethnic Distribution of Phase Sample

Frequency
7

Percent
1.3

Valid
Percent
1.3

Unknown
or prefer
not to
report

18

3.3

3.3

Asian

36

6.6

6.6

Black or
African
American

49

8.9

8.9

Other or
multiracial

54

9.8

9.8

American
Indian/
Alaska
Native

White

385

70.1

70.1

Total

549

100.0

100.0

Table 3. Age Distribution of Phase One Sample

13-17

Frequency
3

Percent
.5

Valid
Percent
.5

55-64

3

.5

.5

35-54

18

3.3

3.3

26-34

27

4.9

4.9

18-25

498

90.7

90.7

Total

549

100.0

100.0
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Table 4. Gender Distribution of Phase One Sample
Frequency
2

Percent
.4

Valid
Percent
.4

Male

151

27.5

27.5

Female

396

72.1

72.1

Total

549

100.0

100.0

Prefer
not to
report

Table 5. Grade Classification of Phase One Sample

Frequency
2

Percent
.4

Valid
Percent
.4

6

1.1

1.1

Senior

73

13.3

13.3

Junior

120

21.9

21.9

Sophomore

125

22.76867

22.76867

Freshman
or first-year
student

223

40.6

40.6

Total

549

100.0

100.0

Graduate
student
Other (e.g.
non-degree
student)
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Table 6. Language Ability of Phase One Sample

Frequency
1

Percent
.2

Valid
Percent
.2

Some familiarity
(e.g., a year of
instruction in school)

1

.2

.2

Limited but
adequate
competence in
speaking, reading,
and writing
Fully competent in
speaking, listening,
reading, and writing,
but not native

3

.5

.5

85

15.5

15.5

Native (learned from
birth)

459

83.6

83.6

Total

549

100.0

100.0

Restricted ability
(e.g., only reading or
only
speaking/listening)

Table 7. Descriptive Statistics of Test Scores of Phase One Sample

N

Minimum

Maximum

Mean

Std. Deviation

CESDRSum

549

.00

55.00

14.8452

12.61631

MASQPastSum

549

8.00

40.00

16.2550

6.27565

MASQRecentSum

549

8.00

39.00

15.1038

6.19322

GADSum

549

.00

21.00

6.8980

5.04800

PSWQSum*

537

17.00

80.00

49.9944

14.06826

Valid N (listwise)

537

*A Qualtrics error at the onset of the study prevented some participants from taking the PSWQ.
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Table 8. Means of Some Scales Used
Did they seek

N

Mean

treatment or not?

Std.

Std. Error

Deviation

Mean

Yes

25

.8933

.45612

.09122

No

10

.9168

.37275

.11787

Yes

25

.8700

.64284

.12857

10

.7417

.50834

.16075

Yes

25

2.2267

.43536

.08707

No

10

2.6170

.36898

.11668

25 63.4000

10.17349

2.03470

10 62.9000

7.65143

2.41960

25 12.6400

3.32766

.66553

10 12.4000

2.91357

.92135

25 23.5200

7.17705

1.43541

10 23.3000

3.52924

1.11604

25 22.3600

7.34212

1.46842

10 22.6000

7.54542

2.38607

25 30.8800

11.49029

2.29806

10 29.3000

8.84496

2.79702

BACE_ToTalMeanValue

BACE_meanTreatstigma

TreatmentStigmaRating

PSWQSum

No

Yes
No

GADSum

Yes
No

MASQRecentSum

Yes
No

MASQPastSum

Yes
No

CESDRSum

Yes
No
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Table 9. Independent Samples T-tests for the Total Mean of BACE and Stigma Items
t-test
for
Equality
of
Means

Levene's Test
for Equality of
Variances

BACE_ToTalMeanValue

Equal
variances
assumed

F
.823

Sig.
.371

Equal
variances
not
assumed
BACE_meanTreatstigma

Equal
variances
assumed

1.984

.168

Equal
variances
not
assumed
TreatmentStigmaRating

Equal
variances
assumed

.770

.387

Equal
variances
not
assumed

35

33

Sig. (2tailed)
.886

Mean
Difference
-.02346

Std. Error
Difference
.16275

-.157

20.281

.876

-.02346

.14905

.563

33

.577

.12833

.22791

.623

20.978

.540

.12833

.20584

-2.494

33

.018

-.39033

.15651

-2.681

19.542

.015

-.39033

.14559

t
-.144

df

Table 10. Independent Samples T-tests for Some Scales Used
Levene's Test for
Equality of
Variances

PSWQSum

Equal
variances
assumed

F
.587

t-test for
Equality
of
Means

Sig.
.449

Equal
variances
not
assumed
GADSum

Equal
variances
assumed

1.357

.252

Equal
variances
not
assumed
MASQRecentSum

Equal
variances
assumed

4.840

.035

Equal
variances
not
assumed
MASQPastSum

Equal
variances
assumed

.011

.918

Equal
variances
not
assumed
CESDRSum

Equal
variances
assumed

.801

33

Sig. (2tailed)
.890

Mean
Difference
.50000

Std. Error
Difference
3.57401

.158

22.087

.876

.50000

3.16140

.199

33

.843

.24000

1.20482

.211

18.912

.835

.24000

1.13658

.092

33

.927

.22000

2.39170

.121

31.292

.904

.22000

1.81823

-.087

33

.931

-.24000

2.76812

-.086

16.235

.933

-.24000

2.80171

.390

33

.699

1.58000

4.05337

.436

21.567

.667

1.58000

3.62000

t
.140

.377

Equal
variances
not
assumed

36

df

Table 11. Frequencies of Diagnoses Made by the MINI Plus 6
Diagnosis of MDD, Past or Present
Frequency

Percent

Valid Percent

Cumulative
Percent

Valid

yes

12

34.3

34.3

34.3

no

23

65.7

65.7

100.0

Total

35

100.0

100.0

Diagnosis of GAD
Frequency

Percent

Valid Percent

Cumulative
Percent

Valid

yes

12

34.3

34.3

34.3

no

23

65.7

65.7

100.0

Total

35

100.0

100.0

Diagnosis of Other, Past or Present
Frequency

Percent

Valid Percent

Cumulative
Percent

Valid

yes

22

62.9

62.9

62.9

no

13

37.1

37.1

100.0

Total

35

100.0

100.0

Number Without a Diagnosis
Frequency

Percent

Valid Percent

Cumulative
Percent

Valid

yes

7

20.0

20.0

20.0

no

28

80.0

80.0

100.0

Total

35

100.0

100.0

37

Table 12. Chi-Square Test Comparing Groups and Their Finances
Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

6.825a

5

.234

Likelihood Ratio

7.471

5

.188

Linear-by-Linear Association

1.038

1

.308

Pearson Chi-Square

N of Valid Cases

35

a. 11 cells (91.7%) have expected count less than 5. The minimum
expected count is .57.

Enough to get
Very poor,

by, but not

Comfortable,

Well to do,

I have never

could not afford

enough for

could afford

could afford

had emotional

health

health

health

health

Prefer not to

or mental health

insurance

insurance

insurance

insurance

answer

problems.

T. Seeker

3

5

10

5

2

0

Non-T. Seeker

1

1

5

1

0

2

Total

4

6

15

6

2

2

Table 13. Chi-Square Test Comparing Groups and Their Gender
Chi-Square Tests
Value

df

Asymp. Sig. (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

.080a

1

.777

Continuity Correctionb

.000

1

1.000

Likelihood Ratio

.079

1

.779

Pearson Chi-Square

Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases

1.000
.078

1

35

38

.780

.564

a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.71.
b. Computed only for a 2x2 table
Count
Gender
female

Total
male

Did they seek treatment or

Yes

21

4

25

not?

No

8

2

10

29

6

35

Total

Table 14. Chi-Square Test Comparing Groups and MDD Past and/or Present
Chi-Square Tests
Value

Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio

df

Asymp. Sig. (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

7.304a

1

.007

5.329

1

.021

10.387

1

.001

Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases

.007
7.096

1

.008
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a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.43.
b. Computed only for a 2x2 table

Count
MDDPastorPresent
yes

Total

no

Did they seek treatment or

Yes

12

13

25

not?

No

0

10

10

12

23

35

Total

39

.006

Table 15. Chi-Square Test Comparing Groups and GAD

Chi-Square Tests
Value

Pearson Chi-Square
Continuity

Correctionb

Likelihood Ratio

df

Asymp. Sig. (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

.114a

1

.735

.000

1

1.000

.116

1

.734

Fisher's Exact Test
Linear-by-Linear Association

1.000
.111

N of Valid Cases

1

.739

35

a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.43.
b. Computed only for a 2x2 table
Count
GADPastorPresent
yes

Total

no

Did they seek treatment or

Yes

9

16

25

not?

No

3

7

10

12

23

35

Total

Table 16. Chi-Square Test Comparing Groups and Sexual Orientation
Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association

6.939a

4

.139

7.733

4

.102

.014

1

.904

N of Valid Cases

35

a. 8 cells (80.0%) have expected count less than 5. The minimum
expected count is .57.

40

.530

Count
What is your sexual orientation?
Heterosexual

Gay or

Bisexual

Lesbian

Total

Prefer not

Other

to answer

(please
specify)

Did they seek

Yes

19

0

2

1

3

25

treatment or not?

No

6

2

1

1

0

10

25

2

3

2

3

35

Total

Table 17. Chi-Square Test Comparing Groups and Ethnicity

Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

Pearson Chi-Square
Likelihood Ratio

1.974a

4

.741

2.759

4

.599

N of Valid Cases

35

a. 8 cells (80.0%) have expected count less than 5. The minimum
expected count is .29.
Crosstab
Count
Ethnicity
asian

Total

black or

other or

unknown or

african

multiracial

prefer not to

american

white

report

Did they seek

Yes

1

1

4

2

17

25

treatment or not?

No

0

1

1

0

8

10

1

2

5

2

25

35

Total

41

Table 18. Chi-Square Test Comparing Groups and Grade Classification

Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

Pearson Chi-Square

.886a

4

.927

Likelihood Ratio

1.146

4

.887

N of Valid Cases

35

a. 7 cells (70.0%) have expected count less than 5. The minimum
expected count is .29.

Crosstab
Count
Classification
freshman or

junior

other (e.g.,

first-year

Total
senior

sophomore

non-degree
student)

Did they seek

Yes

9

6

1

2

7

25

treatment or not?

No

3

2

0

1

4

10

12

8

1

3

11

35

Total

42

Table 19. Chi-Square Test Comparing Groups and GAF Scores

Independent Samples Test
Levene's

t-test for Equality of Means

Test for
Equality of
Variances
F

Sig.

t

df

Sig.

Mean

(2-

Std. Error

95% Confidence

Difference Difference

Interval of the

tailed)

Difference
Lower

Equal
variances
assumed

2.898 .098

1.181

33

.246

-6.08000

5.15021

20.062

.214

-6.08000

4.73802

Upper
-

16.55818

4.39818

GAFScore Equal
variances
not

1.283

15.96137

3.80137

assumed

Group Statistics
Did they seek treatment or

N

Mean

Std. Deviation

Std. Error Mean

not?
Yes

25

74.1200

14.40289

2.88058

No

10

80.2000

11.89584

3.76180

GAFScore
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Appendix A. Phase One Questionnaire
Name: ________________________________
Best contact email: _____________________________
Best contact number



Home phone ____________________
Cell phone _____________________

1.








How old are you?
Under 13
13-17
18-25
26-34
35-54
55-64
65 or over

2.



What is your gender?
Male
Female

3.







What is your year in college?
Freshman or first-year student
Sophomore
Junior
Senior
Graduate student
Other (e.g. non-degree student)

4.




Which of the following best describes you?
Hispanic or Latino
Not Hispanic or Latino
Unknown or prefer not to report

5.








What is your racial background?
American Indian/ Alaska Native
Asian
Black or African American
Native Hawaiian or Other Pacific Islander
White
Other or multiracial
Unknown or prefer not to report

6.


Please rate your overall ability in the English language:
Native (learned from birth)
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Fully competent in speaking, listening, reading, and writing, but not native
Limited but adequate competence in speaking, reading, and writing
Restricted ability (e.g., only reading or only speaking/listening)
Some familiarity (e.g., a year of instruction in school)

7.

Over your lifetime, have you had any significant problems with work, school, or relationships due to a
mental health problem?
No
Yes (please explain in 2 – 3 sentences):









8.

Think back to a time when you struggled with mental health problems, if applicable. On a scale of 1 to 100,
please rate your ability to handle day-to-day functions at that time in areas such as work, school, and
relationships. (Note: 1 means that you were persistently incapable of handling life's problems, and 100 means that
you operated at a level of superior functioning, and life's problems never seemed to get out of hand).
What is your rating? ___
Not applicable
Have any physiological symptoms, like disturbed sleep and/or pains, ever kept you from functioning
normally in areas such as work, school, or relationships?No
Yes (please explain in 2 – 3 sentences):
Pick a number from the scale below that best describes how typical or characteristic each of the items is of
you. There is no right or wrong answers. Indicate your answer for each statement by writing your choice on
the blank next to that statement.

1
Not at all typical

2

3

4

Somewhat typical

5
Very typical

______ If I don't have enough time to do everything, I don't worry about it
______ My worries overwhelm me.
______ I don’t tend to worry about things.
______ Many situations make me worry.
______ I know I shouldn’t worry about things, but I just can’t help it.
______ When I am under pressure, I worry a lot.
______ I am always worrying about something.
______ I find it easy to dismiss worrisome thoughts.
______ As soon as I finish one task, I start to worry about everything else I have to do.
______ I never worry about anything.
______ When there is nothing more I can do about a concern, I don’t worry about it anymore.
______ I’ve been a worrier all my life.
______ I notice that I have been worrying about things.
______ Once I start worrying, I can’t stop.
______ I worry all the time.
______ I worry about projects until they are done.
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9.

Over the last 2 weeks, how often have you been bothered by the following problems? There are no right or
wrong answers. Indicate your answer for each statement by writing your choice on the blank next to that
statement.

0
Not at all

_____

1

___

Several days

2

______

More than half the days

3
Nearly every day

______ Feeling nervous, anxious, or on edge
______ Not being able to stop or control worrying
______ Worrying too much about different things
______ Trouble relaxing
______ Being so restless that it is hard to sit still
______ Becoming easily annoyed or irritable
______ Feeling afraid as if something awful might happen
10. Below is a list of the ways you might have felt or behaved. Indicate how often you have felt this way in the
past two weeks by writing your choice on the blank next to that statement. There are no right or wrong
answers.

0
Not at all or
2 weeks

1
1 – 2 days

2

3

3 – 4 days

less than 1 day

______ My appetite was poor.
______ I could not shake off the blues.
______ I had trouble keeping my mind on what I was doing.
______ I felt depressed.
______ My sleep was restless.
______ I felt sad.
______ I could not get going.
______ Nothing made me happy.
______ I felt like a bad person.
______ I lost interest in my usual activities.
______ I slept much more than usual.
______ I felt like I was moving too slowly.
______ I felt fidgety.
______ I wished I were dead.
______ I wanted to hurt myself.
______ I was tired all the time.
______ I did not like myself.
______ I lost a lot of weight without trying to.
______ I had a lot of trouble getting to sleep.
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______
5 – 7 days

4
Nearly every day for

______ I could not focus on the important things.
11. Below is a list of feelings, sensations, problems, and experiences that people sometimes have. Indicate your
answer for each statement by writing your choice on the blank next to that statement. Use the choice that
best describes how much you have felt or experienced things this way during the past week, including
today.

1
Not at all
Extremely

2
A little bit

3

4

Moderately

______

5

Quite a bit

______ Felt really slowed down
______ Felt unattractive
______ Felt withdrawn from other people
______ Felt really bored
______ Felt like it took extra effort to get started
______ Felt like nothing was very enjoyable
______ Felt like there wasn't anything interesting or fun to do
______ Thought about death or suicide
12. Below is a list of feelings, sensations, problems, and experiences that people sometimes have. Indicate your
answer for each statement by writing your choice on the blank next to that statement. Use the choice that
best describes how much you have felt or experienced things this way during your lifetime, not including
the past week.

1
Not at all
Extremely

2
A little bit

3

4

Moderately

______ Felt really slowed down
______ Felt unattractive
______ Felt withdrawn from other people
______ Felt really bored
______ Felt like it took extra effort to get started
______ Felt like nothing was very enjoyable
______ Felt like there wasn't anything interesting or fun to do
______ Thought about death or suicide
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______
Quite a bit

5

Appendix B. Phase Two Questionnaire
Q2.1 Please read each question carefully before selecting your answer.

Q2.2 Have you ever sought medications for emotional or mental health problems such as feeling sad, blue,
anxious or nervous?



Yes (1)
No (2)

Q2.3 Have you ever sought psychotherapy or counseling for emotional or mental health problems such as feeling
sad, blue, anxious or nervous?



Yes (1)
No (2)

Q2.4 What is your sexual orientation?






Heterosexual (1)
Gay or Lesbian (2)
Bisexual (3)
Prefer not to answer (4)
Other (please specify) (5) ____________________

Q2.5 If you have had emotional or mental health problems, how would you best describe your financial situation
at or around the time when you had those problems?







Very poor, could not afford health insurance (1)
Enough to get by, but not enough for health insurance (2)
Comfortable, could afford health insurance (3)
Well to do, could afford health insurance (4)
Prefer not to answer (5)
I have never had emotional or mental health problems. (6)
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Q3.1 Which of the following professional service provider(s) did you seek? Check all that apply.









Psychologist (1)
Psychiatrist (2)
Licensed Professional Counselor (3)
Licensed Clinical Social Worker (4)
Psychiatric Nurse Practitioner (5)
Physician/family doctor (6)
Registered Nurse (7)
Other (please specify) (8) ____________________

Q3.2 How long ago was your most recent visit to a professional service provider for help? If you cannot
remember or if you did not seek a professional service provider, check N/A.






In the last 6 months (1)
Between 7 months to 1 year ago (2)
1 to 2 years ago (3)
More than 2 years ago (4)
N/A (5)

Q3.3 Please indicate your primary reason(s) for seeking treatment. Check all that apply.








Anxiety (1)
Depression (2)
Problems adjusting to life problems (breakup, divorce, loss of loved one, etc.) (3)
Physiological problems (fatigue, unusual sleep patterns, changes in appetite, bodily aches, etc.) (4)
Prefer not to answer (5)
Not sure (6)
Other (please specific) (7) ____________________

Q3.4 Please indicate your formal diagnosis by a professional service provider. Check all that apply.














Adult Deficit Hyperactivity Disorder (ADHD) (1)
Bipolar Disorder (2)
Depression NOS (3)
Dysthymia (4)
Generalized Anxiety Disorder (GAD) (5)
Major Depressive Disorder (MDD) (6)
Obsessive-Compulsive Disorder (OCD) (7)
Post-Traumatic Stress Disorder (PTSD) (8)
Specific Phobia (please specific which type) (9) ____________________
Social Phobia/Social Anxiety Disorder (10)
Prefer not to answer (11)
Not sure (12)
Other (please specify) (13) ____________________
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Q3.5 If you sought help from a source other than a professional service provider or you sought help in addition
to a professional service provider for mental health problems, please indicate which ones below. Check all that
apply.












Friends (1)
Family (2)
Romantic partner (e.g., boyfriend or girlfriend) (3)
Pastor/minister (4)
Co-workers (5)
Acupuncture (6)
Acupressure (7)
Yoga (8)
Alternative medicine (9)
I only sought help from professional providers. (10)
Other (please specify) (11) ____________________

Answer If If you sought help from a source other than a professiona... Family Is Selected
Q3.6 Please indicate which family member(s) you sought for help. Check all that apply.










Grandfather (1)
Grandmother (2)
Father (3)
Mother (4)
Spouse (husband/wife) (5)
Brother (6)
Sister (7)
Cousin (8)
Other (please specify) (9) ____________________

Q3.7 When was the last time you reached out to a non-professional source for help?





In the last 6 months (1)
Between 7 months and 1 year ago (2)
1 to 2 years ago (3)
More than 2 years ago (4)

Q3.8 Directions: Please choose your answer on a scale from 1 to 5 with 1 being very dissatisfied and 5 being very
satisfied. If you did not receive medications or psychotherapy/counseling, then check Not Applicable next to the
appropriate box. If your answer is 1, please still click on that number or your answer will not be registered.
______ How satisfied are you with the effectiveness of the medications that you received, if any? (1)
______ How satisfied are you with the effectiveness of the psychotherapy or counseling that you received, if any? (2)
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Answer If Please choose your answer on a scale from 1 to 5 with 1 b... How satisfied are you
with the effectiveness of the medications that you received, if any? Is Greater Than or Equal to
1
Q3.9 Please explain, in a few sentences, why you gave the rating that you did for your satisfaction level with the
effectiveness of the medications that you received. Click the next >> button when you are done.

Answer If Please choose your answer on a scale from 1 to 5 with 1 b... How satisfied are you
with the effectiveness of the psychotherapy or counseling that you received, if any? Is Greater
Than or Equal to 1
Q3.10 Please explain, in a few sentences, why you gave the rating that you did for your satisfaction level with the
effectiveness of the psychotherapy/counseling that you received. Click the next >> button when you are done.

Answer If Have you ever sought medications for emotional or mental ... No Is Selected
Q4.1 Did you ever think that you would need mental health services, such as medications, for dealing with
emotional or mental health problems such as feeling sad, blue, anxious, or nervous?




Yes (1)
No (2)
Not sure (3)

Answer If Have you ever sought psychotherapy or counseling for emot... No Is Selected
Q4.2 Did you ever think that you would need mental health services, such as psychotherapy or counseling, for
dealing with emotional or mental health problems such as feeling sad, blue, anxious, or nervous?




Yes (1)
No (2)
Not sure (3)

Q5.1 Directions: Please choose your answer on a scale from 1 to 5 with 1 being not at all helpful and 5 being very
helpful. If your answer is 1, please still click on that number or your answer will not be registered.
______ How helpful, on average, do you think medication is for people your age who have mental health problems? (1)
______ How helpful, on average, do you think psychotherapy or counseling is for people your age who have mental
health problems? (2)
______ How helpful, on average, do you think both medications AND psychotherapy are for people your age who have
mental health problems, when they are used together? (3)
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Q5.2 Please briefly explain your reasoning for giving the rating that you did when you rated the helpfulness of
medications.

Q5.3 Please briefly explain your reasoning for giving the rating that you did when you rated the helpfulness of
psychotherapy or counseling.

Q5.4 Please briefly explain your reasoning for giving the rating that you did when you rated the helpfulness of
both medications and psychotherapy, when they are used together.

Q6.1 The following questions are about your closest friends and family members. Please answer them to the best
of your knowledge. If you are not sure of any question, just click "Not sure."

Q6.2 How many of your closest friends and family members, excluding yourself, have been formally diagnosed
with a mental health problem such as depression or anxiety?






0 (1)
1 (2)
2 (3)
3+ (4)
Not sure (5)

Q6.3 How many of your closest friends and family members, excluding yourself, have had or currently have a
mental health problem, such as depression or anxiety, but have not been formally diagnosed?






0 (1)
1 (2)
2 (3)
3+ (4)
Not sure (5)

Q7.1 How many of your closest friends and family members, excluding yourself, have used only medications but
not psychotherapy or counseling for their mental health problems?






0 (1)
1 (2)
2 (3)
3+ (4)
Not sure (5)
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Answer If How many of your closest friends and family members, excl... 1 Is Selected Or How
many of your closest friends and family members, excl... 2 Is Selected Or How many of your
closest friends and family members, excl... 3+ Is Selected
Q7.2 Directions: Please choose your answer on a scale from 1 to 5 with 1 being not at all helpful and 5 being very
helpful. If your answer is 1, please still click on that number or your answer will not be registered.
______ In general, how helpful do you think the medications were in contributing to their wellbeing? (1)
______ To the best of your knowledge, how helpful do they think the medications were in contributing to their
wellbeing? (2)

Q7.3 How many of your closest friends and family members, excluding yourself, have used only
psychotherapy/counseling but not medications for their mental health problems?






0 (1)
1 (2)
2 (3)
3+ (4)
Not sure (5)

Answer If How many of your closest friends and family members, excl... 1 Is Selected Or How
many of your closest friends and family members, excl... 2 Is Selected Or How many of your
closest friends and family members, excl... 3+ Is Selected
Q7.4 Directions: Please choose your answer on a scale from 1 to 5 with 1 being not at all helpful and 5 being very
helpful. If your answer is 1, please still click on that number or your answer will not be registered.
______ In general, how helpful do you think the psychotherapy or counseling was in contributing to their wellbeing?
(1)
______ To the best of your knowledge, how helpful do they think the psychotherapy or counseling was in contributing
to their wellbeing? (2)

Q7.5 How many of your closest friends and family members, excluding yourself, have used BOTH
psychotherapy AND medications for their mental health problems?






0 (1)
1 (2)
2 (3)
3+ (4)
Not sure (5)
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Answer If How many of your closest friends and family members, excl... 1 Is Selected Or How
many of your closest friends and family members, excl... 2 Is Selected Or How many of your
closest friends and family members, excl... 3+ Is Selected
Q7.6 Directions: Please choose your answer on a scale from 1 to 5 with 1 being not at all helpful and 5 being very
helpful. If your answer is 1, please still click on that number or your answer will not be registered.
______ In general, how helpful do you think medications AND psychotherapy were (when used together) in
contributing to their wellbeing? (1)
______ To the best of your knowledge, how helpful do they think the medications AND psychotherapy were (when
used together) in contributing to their wellbeing? (2)

Q8.1 For the following questions, think of your closest friend or family member. If you cannot decide on just
one, pick the person with whom you spend more time.

Q8.2 Who is your closest friend or family member who has used medications and/or psychotherapy?













Grandfather (1)
Grandmother (2)
Father (3)
Mother (4)
Spouse (5)
Child (6)
Brother (7)
Sister (8)
Cousin (9)
Friend (10)
Romantic partner (11)
Other (please specify) (12) ____________________

Q8.3 Which of the following professional service provider(s) did he or she seek? Check all that apply.









Psychologist (1)
Psychiatrist (2)
Licensed Professional Counselor (3)
Licensed Clinical Social Worker (4)
Psychiatric Nurse Practitioner (5)
Physician/family doctor (6)
Registered Nurse (7)
Other (please specify) (8) ____________________
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Q8.4 How long ago was his or her most recent visit to a professional service provider for help? If you cannot
remember, you don't know, or if he or she did not seek a professional service provider, check N/A.






In the last 6 months (1)
Between 7 months to 1 year ago (2)
1 to 2 years ago (3)
More than 2 years ago (4)
N/A (5)

Q8.5 Please indicate his or her primary reason(s) for seeking treatment. Check all that apply.








Anxiety (1)
Depression (2)
Problems adjusting to life problems (breakup, divorce, loss of loved one, etc.) (3)
Physiological problems (fatigue, unusual sleep patterns, changes in appetite, bodily aches, etc.) (4)
Prefer not to answer (5)
Not sure (6)
Other (please specific) (7) ____________________

Q8.6 Please indicate his or her formal diagnosis by a professional service provider. Check all that apply.














Adult Deficit Hyperactivity Disorder (ADHD) (1)
Bipolar Disorder (2)
Depression NOS (3)
Dysthymia (4)
Generalized Anxiety Disorder (GAD) (5)
Major Depressive Disorder (MDD) (6)
Obsessive-Compulsive Disorder (OCD) (7)
Post-Traumatic Stress Disorder (PTSD) (8)
Specific Phobia (please specific which type) (9) ____________________
Social Phobia/Social Anxiety Disorder (10)
Prefer not to answer (11)
Not sure (12)
Other (please specify) (13) ____________________
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Q8.7 If he or she sought help from anything other than a professional service provider for mental health
problems, please indicate which ones below. Check all that apply.












Friends (1)
Family (2)
Romantic partner (e.g., boyfriend or girlfriend) (3)
Pastor/minister (4)
Co-workers (5)
Acupuncture (6)
Acupressure (7)
Yoga (8)
Alternative medicine (9)
He or she only sought help from professional providers. (10)
Other (please specify) (11) ____________________

Answer If If he or she sought help from anything other than a profe... Family Is Selected
Q8.8 Please indicate which family member(s) he or she sought for help. Check all that apply.











Grandfather (1)
Grandmother (2)
Father (3)
Mother (4)
Spouse (husband/wife) (5)
Brother (6)
Sister (7)
Cousin (8)
Not sure (9)
Other (please specify) (10) ____________________

Answer If If he or she sought help from anything other than a profe... He or she only sought help
from professional providers. Is Not Selected
Q8.9 When was the last time he or she reached out to a non-professional source of help?







In the last 6 months (1)
Between 7 months and 1 year ago (2)
1 to 2 years ago (3)
More than 2 years ago (4)
Not sure (5)
N/A (6)

Q8.10 Did this close friend or family member affect your decision to seek or not seek treatment in any way?
Please state either Yes or No then explain in a few sentences.
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Q9.1 For the following items, please circle an answer from 1 to 5, with 1 being strongly disagree and 5 being
strongly agree.
______ I think less of a person who has received mental health treatment. (1)
______ Most people would willingly accept someone who has received mental health treatment as a close friend. (2)
______ Most people feel that receiving mental health treatment is a sign of personal failure. (3)
______ I would willingly accept someone who has received mental health treatment as a close friend. (4)
______ Most people think less of a person who has received mental health treatment. (5)
______ I feel that receiving mental health treatment is a sign of personal failure. (6)
Q10.1 Below is a list of things which can stop, delay or discourage people from getting professional care for a
mental health problem, or continuing to get help. By professional care we mean care from such staff as a family
doctor, community mental health team (e.g. care coordinator, mental health nurse or mental health social
worker), psychiatrist, counselor, psychologist or psychotherapist. Have any of these issues ever stopped,
delayed or discouraged you from getting, or continuing with, professional care for a mental health
problem? Please select one number on each row to indicate the answer that best suits you. Note: Even if your
answer is 0 please click on that number or your answer will be not registered. For ‘not applicable’ e.g. if it is a
question about children and you do not have children, please click 0 and write N/A in the provided text box.
______ Being unsure where to go to get professional care (1)
______ Wanting to solve the problem on my own (2)
______ Concern that I might be seen as weak for having a mental health problem (3)
______ Fear of being put in hospital against my will (4)
______ Concern that it might harm my chances when applying for jobs. (please click 0 and type N/A if not applicable)
(5)
______ Problems with transportation or travelling to appointments (6)
______ Thinking the problem would get better by itself (7)
______ Concern about what my family might think, say, do or feel (8)
______ Feeing embarrassed or ashamed (9)
______ Preferring to get alternative forms of care (e.g. traditional / religious healing or alternative / complementary
therapies) (10)
______ Not being able to afford the financial costs involved (11)
______ Concern that I might be seen as ‘crazy’ (12)
______ Thinking that professional care probably would not help (13)
______ Concern that I might be seen as a bad parent (please click 0 and type N/A if not applicable) (14)
______ Professionals from my own ethnic or cultural group not being available (15)
______ Being too unwell to ask for help (16)
______ Concern that people I know might find out (17)
______ Dislike of talking about my feelings, emotions or thoughts (18)
______ Concern that people might not take me seriously if they found out I was having professional care (19)
______ Concerns about the treatments available (e.g. medication side effects) (20)
______ Not wanting a mental health problem to be on my medical records (21)
______ Having had previous bad experiences with professional care for mental health (please click 0 and type N/A if
not applicable) (22)
______ Preferring to get help from family or friends (23)
______ Concern that my children may be taken into care or that I may lose access or custody without my agreement
(please click 0 and type N/A if not applicable) (24)
______ Thinking I did not have a problem (25)
______ Concern about what my friends might think, say or do (26)
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______ Difficulty taking time off work (please click 0 and type N/A if not applicable) (27)
______ Concern about what people at work might think, say or do (please click 0 and type N/A if not applicable) (28)
______ Having problems with childcare while I receive professional care (please click 0 and type N/A if not
applicable) (29)
______ Having no one who could help me get professional care (30)

Q10.2 If you have any additional thoughts or comments about attitudes, beliefs, and behaviors toward treatment
seeking, please provide them in the empty space below.

Q10.3 Thank you for your participation.
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